A map of transcriptional heterogeneity and regulatory variation in human microglia.


Journal

Nature genetics
ISSN: 1546-1718
Titre abrégé: Nat Genet
Pays: United States
ID NLM: 9216904

Informations de publication

Date de publication:
06 2021
Historique:
received: 15 05 2020
accepted: 23 04 2021
pubmed: 5 6 2021
medline: 21 7 2021
entrez: 4 6 2021
Statut: ppublish

Résumé

Microglia, the tissue-resident macrophages of the central nervous system (CNS), play critical roles in immune defense, development and homeostasis. However, isolating microglia from humans in large numbers is challenging. Here, we profiled gene expression variation in primary human microglia isolated from 141 patients undergoing neurosurgery. Using single-cell and bulk RNA sequencing, we identify how age, sex and clinical pathology influence microglia gene expression and which genetic variants have microglia-specific functions using expression quantitative trait loci (eQTL) mapping. We follow up one of our findings using a human induced pluripotent stem cell-based macrophage model to fine-map a candidate causal variant for Alzheimer's disease at the BIN1 locus. Our study provides a population-scale transcriptional map of a critically important cell for human CNS development and disease.

Identifiants

pubmed: 34083789
doi: 10.1038/s41588-021-00875-2
pii: 10.1038/s41588-021-00875-2
pmc: PMC7610960
mid: EMS123217
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

861-868

Subventions

Organisme : Medical Research Council
ID : MC_PC_17230
Pays : United Kingdom
Organisme : Wellcome Trust
ID : RRZD/029
Pays : United Kingdom
Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : Wellcome Trust
ID : 206194
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203151
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Références

Schafer, D. P. & Stevens, B. Microglia function in central nervous system development and plasticity. Cold Spring Harb. Perspect. Biol. 7, a020545 (2015).
pubmed: 26187728 pmcid: 4588063 doi: 10.1101/cshperspect.a020545
Li, Q. & Barres, B. A. Microglia and macrophages in brain homeostasis and disease. Nat. Rev. Immunol. 18, 225–242 (2018).
pubmed: 29151590 doi: 10.1038/nri.2017.125
Salter, M. W. & Stevens, B. Microglia emerge as central players in brain disease. Nat. Med. 23, 1018–1027 (2017).
pubmed: 28886007 doi: 10.1038/nm.4397
Guerreiro, R. et al. TREM2 variants in Alzheimer’s disease. N. Engl. J. Med. 368, 117–127 (2013).
pubmed: 23150934 doi: 10.1056/NEJMoa1211851
Jonsson, T. et al. Variant of TREM2 associated with the risk of Alzheimer’s disease. N. Engl. J. Med. 368, 107–116 (2013).
pubmed: 23150908 doi: 10.1056/NEJMoa1211103
Tansey, K. E., Cameron, D. & Hill, M. J. Genetic risk for Alzheimer’s disease is concentrated in specific macrophage and microglial transcriptional networks. Genome Med. 10, 14 (2018).
pubmed: 29482603 pmcid: 5828245 doi: 10.1186/s13073-018-0523-8
Gjoneska, E. et al. Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer’s disease. Nature 518, 365–369 (2015).
pubmed: 25693568 pmcid: 4530583 doi: 10.1038/nature14252
Olah, M. et al. A transcriptomic atlas of aged human microglia. Nat. Commun. 9, 539 (2018).
pubmed: 29416036 pmcid: 5803269 doi: 10.1038/s41467-018-02926-5
Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer’s disease. Cell 169, 1276–1290.e17 (2017).
pubmed: 28602351 doi: 10.1016/j.cell.2017.05.018
Hammond, T. R. et al. Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes. Immunity 50, 253–271.e6 (2019).
pubmed: 30471926 doi: 10.1016/j.immuni.2018.11.004
Masuda, T. et al. Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution. Nature 566, 388–392 (2019).
pubmed: 30760929 doi: 10.1038/s41586-019-0924-x
Mrdjen, D. et al. High-dimensional single-cell mapping of central nervous system immune cells reveals distinct myeloid subsets in health, aging, and disease. Immunity 48, 380–395.e6 (2018).
pubmed: 29426702 doi: 10.1016/j.immuni.2018.01.011
Mathys, H. et al. Temporal tracking of microglia activation in neurodegeneration at single-cell resolution. Cell Rep. 21, 366–380 (2017).
pubmed: 29020624 pmcid: 5642107 doi: 10.1016/j.celrep.2017.09.039
Kilpinen, H. et al. Common genetic variation drives molecular heterogeneity in human iPSCs. Nature 546, 370–375 (2017).
pubmed: 28489815 pmcid: 5524171 doi: 10.1038/nature22403
Picelli, S. et al. Full-length RNA-seq from single cells using Smart-seq2. Nat. Protoc. 9, 171–181 (2014).
pubmed: 24385147 doi: 10.1038/nprot.2014.006
Zhang, Y. et al. Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron 89, 37–53 (2016).
pubmed: 26687838 doi: 10.1016/j.neuron.2015.11.013
Gosselin, D. et al. An environment-dependent transcriptional network specifies human microglia identity. Science 356, eaal3222 (2017).
pubmed: 28546318 pmcid: 5858585 doi: 10.1126/science.aal3222
Zheng, G. X. Y. et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 8, 14049 (2017).
pubmed: 28091601 pmcid: 5241818 doi: 10.1038/ncomms14049
Habib, N. et al. Massively parallel single-nucleus RNA-seq with DroNc-seq. Nat. Methods 14, 955–958 (2017).
pubmed: 28846088 pmcid: 5623139 doi: 10.1038/nmeth.4407
Mathys, H. et al. Single-cell transcriptomic analysis of Alzheimer’s disease. Nature 570, 332–337 (2019).
pubmed: 31042697 pmcid: 6865822 doi: 10.1038/s41586-019-1195-2
Sankowski, R. et al. Mapping microglia states in the human brain through the integration of high-dimensional techniques. Nat. Neurosci. 22, 2098–2110 (2019).
pubmed: 31740814 doi: 10.1038/s41593-019-0532-y
Kumasaka, N., Knights, A. J. & Gaffney, D. J. Fine-mapping cellular QTLs with RASQUAL and ATAC-seq. Nat. Genet. 48, 206–213 (2016).
pubmed: 26656845 doi: 10.1038/ng.3467
Jansen, I. et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk. Nat. Genet. 51, 404–413 (2019).
pubmed: 30617256 pmcid: 6836675 doi: 10.1038/s41588-018-0311-9
Kunkle, B. W. et al. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nat. Genet. 51, 414–430 (2019).
pubmed: 30820047 pmcid: 6463297 doi: 10.1038/s41588-019-0358-2
Lambert, J. C. et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat. Genet. 45, 1452–1458 (2013).
pubmed: 24162737 pmcid: 3896259 doi: 10.1038/ng.2802
Marioni, R. E. et al. GWAS on family history of Alzheimer’s disease. Transl. Psychiatry 8, 99 (2018).
pubmed: 29777097 pmcid: 5959890 doi: 10.1038/s41398-018-0150-6
Schwartzentruber, J. et al. Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer’s disease risk genes. Nat. Genet. 53, 392–402 (2021).
pubmed: 33589840 pmcid: 7610386 doi: 10.1038/s41588-020-00776-w
Raj, T. et al. CD33: increased inclusion of exon 2 implicates the Ig V-set domain in Alzheimer’s disease susceptibility. Hum. Mol. Genet. 23, 2729–2736 (2014).
pubmed: 24381305 doi: 10.1093/hmg/ddt666
Alasoo, K. et al. Shared genetic effects on chromatin and gene expression indicate a role for enhancer priming in immune response. Nat. Genet. 50, 424–431 (2018).
pubmed: 29379200 pmcid: 6548559 doi: 10.1038/s41588-018-0046-7
Barbosa, A. C. et al. MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function. Proc. Natl Acad. Sci. USA 105, 9391–9396 (2008).
pubmed: 18599438 pmcid: 2453723 doi: 10.1073/pnas.0802679105
Nott, A. et al. Brain cell type-specific enhancer-promoter interactome maps and disease-risk association. Science 366, 1134–1139 (2019).
pubmed: 31727856 pmcid: 7028213 doi: 10.1126/science.aay0793
Vela, J. M., Yáñez, A., González, B. & Castellano, B. Time course of proliferation and elimination of microglia/macrophages in different neurodegenerative conditions. J. Neurotrauma 19, 1503–1520 (2002).
pubmed: 12490014 doi: 10.1089/089771502320914723
Abud, E. M. et al. iPSC-derived human microglia-like cells to study neurological diseases. Neuron 94, 278–293.e9 (2017).
pubmed: 28426964 pmcid: 5482419 doi: 10.1016/j.neuron.2017.03.042
Okbay, A. et al. Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses. Nat. Genet. 48, 624–633 (2016).
pubmed: 27089181 pmcid: 4884152 doi: 10.1038/ng.3552
Luciano, M. et al. Association analysis in over 329,000 individuals identifies 116 independent variants influencing neuroticism. Nat. Genet. 50, 6–11 (2018).
pubmed: 29255261 doi: 10.1038/s41588-017-0013-8
Alasoo, K. et al. Transcriptional profiling of macrophages derived from monocytes and iPS cells identifies a conserved response to LPS and novel alternative transcription. Sci. Rep. 5, 12524 (2015).
pubmed: 26224331 pmcid: 4519778 doi: 10.1038/srep12524
Douvaras, P. et al. Directed differentiation of human pluripotent stem cells to microglia. Stem Cell Rep. 8, 1516–1524 (2017).
doi: 10.1016/j.stemcr.2017.04.023
Muffat, J. et al. Efficient derivation of microglia-like cells from human pluripotent stem cells. Nat. Med. 22, 1358–1367 (2016).
pubmed: 27668937 pmcid: 5101156 doi: 10.1038/nm.4189
Zhang, H. et al. Functional analysis and transcriptomic profiling of iPSC-derived macrophages and their application in modeling Mendelian disease. Circ. Res. 117, 17–28 (2015).
pubmed: 25904599 pmcid: 4565503 doi: 10.1161/CIRCRESAHA.117.305860
Chen, L. et al. Genetic drivers of epigenetic and transcriptional variation in human immune cells. Cell 167, 1398–1414.e24 (2016).
pubmed: 27863251 pmcid: 5119954 doi: 10.1016/j.cell.2016.10.026
Jiang, H., Lei, R., Ding, S.-W. & Zhu, S. Skewer: a fast and accurate adapter trimmer for next-generation sequencing paired-end reads. BMC Bioinform. 15, 182 (2014).
doi: 10.1186/1471-2105-15-182
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
pubmed: 23104886 doi: 10.1093/bioinformatics/bts635
Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923–930 (2014).
pubmed: 24227677 doi: 10.1093/bioinformatics/btt656
Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics 25, 1754–1760 (2009).
pubmed: 19451168 pmcid: 2705234 doi: 10.1093/bioinformatics/btp324
Kumasaka, N., Knights, A. J. & Gaffney, D. J. High-resolution genetic mapping of putative causal interactions between regions of open chromatin. Nat. Genet. 51, 128–137 (2019).
pubmed: 30478436 doi: 10.1038/s41588-018-0278-6
Kang, H. M. et al. Multiplexed droplet single-cell RNA-sequencing using natural genetic variation. Nat. Biotechnol. 36, 89–94 (2018).
pubmed: 29227470 doi: 10.1038/nbt.4042
Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289–1296 (2019).
pubmed: 31740819 pmcid: 6884693 doi: 10.1038/s41592-019-0619-0
Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411–420 (2018).
pubmed: 29608179 pmcid: 6700744 doi: 10.1038/nbt.4096
Haghverdi, L., Lun, A. T. L., Morgan, M. D. & Marioni, J. C. Batch effects in single-cell RNA-sequencing data are corrected by matching mutual nearest neighbors. Nat. Biotechnol. https://doi.org/10.1038/nbt.4091 (2018)
Giambartolomei, C. et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 10, e1004383 (2014).
pubmed: 24830394 pmcid: 4022491 doi: 10.1371/journal.pgen.1004383
Veyrieras, J.-B. et al. High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet. 4, e1000214 (2008).
pubmed: 18846210 pmcid: 2556086 doi: 10.1371/journal.pgen.1000214

Auteurs

Adam M H Young (AMH)

Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK.

Natsuhiko Kumasaka (N)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.

Fiona Calvert (F)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.

Timothy R Hammond (TR)

FM Kirby Neurobiology Center, Boston Children's Hospital Harvard University, Boston, MA, USA.
Howard Hughes Medical Institute, Broad Institute of Harvard and MIT, Boston, MA, USA.

Andrew Knights (A)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.

Nikolaos Panousis (N)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.

Jun Sung Park (JS)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.

Jeremy Schwartzentruber (J)

EMBL-EBI, Wellcome Genome Campus, Hinxton, UK.

Jimmy Liu (J)

Biogen, Cambridge, MA, USA.

Kousik Kundu (K)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.

Michael Segel (M)

Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.

Natalia A Murphy (NA)

Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.

Christopher E McMurran (CE)

Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.

Harry Bulstrode (H)

Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK.

Jason Correia (J)

Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK.

Karol P Budohoski (KP)

Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK.

Alexis Joannides (A)

Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK.

Mathew R Guilfoyle (MR)

Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK.

Rikin Trivedi (R)

Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK.

Ramez Kirollos (R)

Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK.

Robert Morris (R)

Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK.

Matthew R Garnett (MR)

Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK.

Ivan Timofeev (I)

Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK.

Ibrahim Jalloh (I)

Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK.

Katherine Holland (K)

Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK.

Richard Mannion (R)

Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK.

Richard Mair (R)

Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK.

Colin Watts (C)

Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK.
Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, Birmingham, UK.

Stephen J Price (SJ)

Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK.

Peter J Kirkpatrick (PJ)

Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK.

Thomas Santarius (T)

Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK.

Edward Mountjoy (E)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
Open Targets, Wellcome Genome Campus, Hinxton, UK.

Maya Ghoussaini (M)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
Open Targets, Wellcome Genome Campus, Hinxton, UK.

Nicole Soranzo (N)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.

Omer A Bayraktar (OA)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.

Beth Stevens (B)

FM Kirby Neurobiology Center, Boston Children's Hospital Harvard University, Boston, MA, USA.
Howard Hughes Medical Institute, Broad Institute of Harvard and MIT, Boston, MA, USA.

Peter J Hutchinson (PJ)

Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK.

Robin J M Franklin (RJM)

Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. rjf1000@cam.ac.uk.

Daniel J Gaffney (DJ)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK. dg13@sanger.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH